Peter Garrambone, Jr.
Partner and Co-head of North American Transactions
New York Office
Pete is a seasoned pharmaceutical industry financial and business development officer, where he spent more than 25 years working in business development at Pfizer and Reliant Pharmaceuticals. Pete joined Torreya Partners in 2008 and serves as the co-head of North American Transactions Advisory.
Pete led and completed more than 50 licensing and M&A transactions worth over $250 billion as a business development professional.
Pete was interim- CEO of Aegerion Pharmaceuticals in 2009. From 2007 to 2008, he was Senior Vice President of Business Development at Reliant Pharmaceuticals. Prior to this, Pete worked at Pfizer for 24 years, where he served Vice President of Business Development in Pfizer’s Hospital Products Group, Vice President of Finance for Pfizer’s U.S. Pharmaceutical Group, Senior Vice President of Pfizer’s Medical Technology Group, Vice President of Corporate Finance, and Senior Vice President of Corporate Strategic Planning and Business Development. While at Pfizer, Pete led and assisted on numerous acquisitions, divestitures and strategic planning and evaluation processes.
Some notable past transaction work prior to joining Torreya includes Reliant Pharmaceuticals sale to GlaxoSmithKline for $1.65 billion; Pfizer’s $117 billion acquisition of Warner-Lambert; Pfizer’s $56 billion acquisition of Pharmacia; Pfizer’s $1.3 billion acquisition of Esperion; Pfizer’s $1.9 billion acquisition of Vicuron; Pfizer’s divestiture of consumer healthcare business to J&J for $16.6 billion; Pfizer’s divestiture of Schneider to Boston Scientific for $2.1 billion and Pfizer’s divestiture of Howmedica to Stryker for $1.65 billion.
Pete earned his undergraduate degree from Colby College and holds an MBA from the Tuck School of Business at Dartmouth.
Pete is a registered representative with Financial West Group.